A new medical device could help doctors to predict the extent of your cardiac condition, a British medical device manufacturer has announced.
The Fitbounds heart monitoring device is a portable device that is implanted under the skin.
It can monitor the heart’s electrical activity, and help to diagnose cardiac problems.
The device is not currently used to diagnose the heart condition, but it could be useful for patients with the condition.
The new device, which can measure electrical activity in the heart, has been developed by Fitbounded.
The company is working with British firm Gartner and has made the announcement on its website.
Fitbound says the device can detect heart conditions in five to 15 minutes and will provide a more accurate diagnosis than current devices.
It is currently available in Britain and will be available globally in a year or so.
Fitbit is one of the most successful companies in the health sector, with more than 2.3 million devices in use worldwide, according to Fitbit CEO Mark DiCarlo.
In May 2016, Fitbit sold more than 30 million Fitbits to its customers worldwide.
In the US, the company is in talks with the Federal Trade Commission (FTC) to help regulators develop new standards for Fitbits.
“We are pleased to be collaborating with Fitbit to further our vision of a wireless heart monitoring system that is compliant with all applicable regulations,” said Gartners Chief Marketing Officer John Leung.
The Fitbit heart device is still under development and will not be commercially available until 2021.
It is the first heart monitoring technology that will work with wearable technology, such as a Fitbit device, FitBounds wearable technology or an Apple Watch.
While the device is more expensive than a pacemaker, the Fitbit Heart is expected to be less expensive than traditional pacemakers, which cost about $1,000.